ATE355286T1 - Verfahren zur herstellung von pioglitazone als antidiabetisches mitttel - Google Patents

Verfahren zur herstellung von pioglitazone als antidiabetisches mitttel

Info

Publication number
ATE355286T1
ATE355286T1 AT02734989T AT02734989T ATE355286T1 AT E355286 T1 ATE355286 T1 AT E355286T1 AT 02734989 T AT02734989 T AT 02734989T AT 02734989 T AT02734989 T AT 02734989T AT E355286 T1 ATE355286 T1 AT E355286T1
Authority
AT
Austria
Prior art keywords
sup
formula
group
residue
general formula
Prior art date
Application number
AT02734989T
Other languages
English (en)
Inventor
Ales Halama
Ludmila Hejtmankova
Petr Lustig
Jindrich Richter
Lucie Srsnova
Josef Jirman
Original Assignee
Zentiva As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CZ20011501A external-priority patent/CZ290353B6/cs
Priority claimed from CZ20011502A external-priority patent/CZ20011502A3/cs
Application filed by Zentiva As filed Critical Zentiva As
Application granted granted Critical
Publication of ATE355286T1 publication Critical patent/ATE355286T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pyridine Compounds (AREA)
AT02734989T 2001-04-26 2002-04-25 Verfahren zur herstellung von pioglitazone als antidiabetisches mitttel ATE355286T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ20011501A CZ290353B6 (cs) 2001-04-26 2001-04-26 Způsob výroby meziproduktu pro výrobu antidiabetika
CZ20011502A CZ20011502A3 (cs) 2001-04-26 2001-04-26 Způsob výroby antidiabetika

Publications (1)

Publication Number Publication Date
ATE355286T1 true ATE355286T1 (de) 2006-03-15

Family

ID=25746959

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02734989T ATE355286T1 (de) 2001-04-26 2002-04-25 Verfahren zur herstellung von pioglitazone als antidiabetisches mitttel

Country Status (11)

Country Link
US (1) US7009057B2 (de)
EP (1) EP1387843B1 (de)
AT (1) ATE355286T1 (de)
AU (1) AU2002311057A1 (de)
DE (1) DE60218449D1 (de)
EE (1) EE200300519A (de)
HU (1) HUP0400091A2 (de)
PL (1) PL363738A1 (de)
RU (1) RU2281285C2 (de)
SK (1) SK14452003A3 (de)
WO (1) WO2002088120A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004007490A2 (en) * 2002-07-16 2004-01-22 Cadila Healthcare Limited A process to prepare pioglitazone via several intermediates.
US8993773B2 (en) 2002-07-16 2015-03-31 Cadila Healthcare Limited Process to prepare pioglitazone via several novel intermediates
WO2004108721A1 (en) * 2003-04-01 2004-12-16 Sun Pharmaceutical Industries Limited Process for the preparation of 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl] methyl]-2,4-thiazolidinedione
ES2219180B1 (es) * 2003-05-09 2006-03-01 Medichem, S.A. Compuesto intermedio util para la preparacion de pioglitazona.
US7230016B2 (en) 2003-05-13 2007-06-12 Synthon Ip Inc. Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
US20050059708A1 (en) * 2003-05-13 2005-03-17 Karel Pospisilik Processes for making thiazolidinedione derivatives and compounds thereof
US20070078170A1 (en) * 2003-08-28 2007-04-05 Khanduri Chandra H Process for the preparation of pioglitazone
CN1319956C (zh) * 2003-09-12 2007-06-06 深圳市海粤门生物科技开发有限公司 一种噻唑烷二酮的衍生物及其药用制剂的制备方法和应用
WO2005080387A2 (en) 2004-02-20 2005-09-01 Synthon B.V. Processes for making pioglitazone and compounds of the processes
US7402713B2 (en) * 2006-03-07 2008-07-22 E.I. Du Pont De Nemours And Company Processes for conversion of tyrosine to p-hydroxystyrene and p-acetoxystyrene
ES2388555T3 (es) 2006-03-16 2012-10-16 Metabolic Solutions Development Company Llc Análogos de tiazolidindiona
ES2397944T3 (es) 2006-03-16 2013-03-12 Metabolic Solutions Development Company Llc Análogos de tiazolidindiona
KR100791400B1 (ko) 2006-09-06 2008-01-07 동우신테크 주식회사 티아졸리딘디온 유도체의 제조방법
ES2398313T3 (es) 2007-09-14 2013-03-15 Metabolic Solutions Development Company Llc 5-(4-(2-(3-metoxifenil)-2-oxoetoxi)bencil)tiazolidin-2,4-diona para uso en el tratamiento de la diabetes
US8304441B2 (en) 2007-09-14 2012-11-06 Metabolic Solutions Development Company, Llc Thiazolidinedione analogues for the treatment of metabolic diseases
WO2009148195A1 (en) * 2008-06-02 2009-12-10 Daebong Ls, Ltd. 5-(4-hydroxybenzyl)thiazolidine-2,4-dione as intermediate for synthesis of thiazolidinedione based compounds and process for preparing the same
KR102029611B1 (ko) 2009-12-15 2019-10-07 씨리우스 테라퓨틱스, 엘엘씨 대사성 질환의 치료를 위한 ｐｐａｒ 절약형 티아졸리딘디온염
CN108003090A (zh) * 2018-01-05 2018-05-08 白银亿尔精细化工有限公司 一种制备4-[2-(5-乙基-2-吡啶基)乙氧基]硝基苯的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57209274A (en) * 1981-06-16 1982-12-22 Takeda Chem Ind Ltd Urea derivative, its preparation and its use
AR240698A1 (es) 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
JPS62205054A (ja) * 1986-03-05 1987-09-09 Takeda Chem Ind Ltd 尿素誘導体
US5952509A (en) * 1996-06-27 1999-09-14 Takeda Chemical Industries, Ltd. Production of benzaldehyde compounds
JP4316787B2 (ja) 2000-01-11 2009-08-19 壽製薬株式会社 エーテル又はアミド誘導体、その製法並びにそれを含有する糖尿病治療剤、

Also Published As

Publication number Publication date
HUP0400091A2 (hu) 2004-06-28
DE60218449D1 (de) 2007-04-12
EP1387843B1 (de) 2007-02-28
RU2003134542A (ru) 2005-06-10
WO2002088120A1 (en) 2002-11-07
EE200300519A (et) 2004-02-16
EP1387843A1 (de) 2004-02-11
SK14452003A3 (sk) 2004-04-06
PL363738A1 (en) 2004-11-29
WO2002088120B1 (en) 2004-02-26
US7009057B2 (en) 2006-03-07
US20050043360A1 (en) 2005-02-24
RU2281285C2 (ru) 2006-08-10
AU2002311057A1 (en) 2002-11-11

Similar Documents

Publication Publication Date Title
ATE355286T1 (de) Verfahren zur herstellung von pioglitazone als antidiabetisches mitttel
MEP7808A (en) Process for preparing 4-trifluoromethylsulphinylpyrazole derivative
ATE348814T1 (de) Verfahren zur herstellung von chinolinderivaten
DE50005699D1 (de) Verfahren zur herstellung von thiazolidin
ATE442363T1 (de) Verfahren zur herstellung von pyridinverbindungen
ATE373071T1 (de) Zusammensetzung und verfahren zur behandlung von halbleitersubstraten
DE60104704D1 (de) Verfahren zur herstellung einer substituierten imidazopyridinverbindung
ATE419230T1 (de) Verfahren zur herstellung von 2,6-dihalo-para- trifluoromethylanilin
DE50100698D1 (de) Verfahren zur Herstellung von 1,3,6-Hexantricarbonitril
ATE380171T1 (de) Verfahren zur herstellung von terbinafine
BR0015163A (pt) Substrato enzimático, processo de sìntese de um substrato enzimático, composição e processo para a detecção e/ou a identificação e/ou a quantificação de pelo menos um microorganismo, kit de diagnóstico e utilização de um substrato enzimático
ATE528358T1 (de) Verfahren zur herstellung einer azoverbindung
DE60308204D1 (de) Verfahren zur herstellung von aminopyrrolidinderivaten
DE60125386D1 (de) Verfahren zur Prävention einer durch Gefrieren induzierten Abnahme der Aktivität eines Proteins
DE69518252D1 (de) Verfahren zur herstellung von 5,6-dihydroxy-2-amino-1,2,3,4-tetrahydronaphthalin-derivaten
ATE251616T1 (de) Verfahren zur herstellung von 5- hydroxymethylthiazole
ATE240945T1 (de) Verfahren zur herstellung von 4-((2',5'-diamino- 6'-halogenpyrimidin-4'-yl)amino)-cyclopent-2- enylmethanolen
ATE372974T1 (de) Verfahren zur herstellung von allylethern
RS51050B (sr) Postupak za dobijanje derivata 4-trifluorometilsulfinil pirazola
ATE286881T1 (de) Verfahren zur zyklisierung von optisch aktiven 4- amino-2-halogenbuttersäuren
DE60028998D1 (de) Verfahren zur herstellung einer benzylamin-verbindung
EP1035125A3 (de) 2-Pyridylsilan, Verfahren zur deren Herstellung und Verwendung
DE60306506D1 (de) Verfahren
ATE205497T1 (de) Verfahren zur herstellung von 3-norcephem- verbindungen
ATE312071T1 (de) Verfahren zur herstellung von vanillylamin hydrochlorid

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties